Human medicines European public assessment report (EPAR): Dengvaxia, dengue tetravalent vaccine (live, attenuated), Date of authorisation: 12/12/2018, Revision: 7, Status: Withdrawn

Human medicines European public assessment report (EPAR): Dengvaxia, dengue tetravalent vaccine (live, attenuated), Date of authorisation: 12/12/2018, Revision: 7, Status: Withdrawn

Human medicines European public assessment report (EPAR): Hetlioz, tasimelteon, Date of authorisation: 03/07/2015, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Hetlioz, tasimelteon, Date of authorisation: 03/07/2015, Revision: 9, Status: Authorised

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2025, 11:

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2025, 11:00 (CET) to 18 November 2025, 12:00 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness